Biogen (BIIB) News Today $125.81 -0.49 (-0.39%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$125.81 0.00 (0.00%) As of 05/23/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIIB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 33.1% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,533,813 shares of the biotechnology company's stock after buyingMay 25 at 5:07 AM | marketbeat.comUSS Investment Management Ltd Has $4.82 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)USS Investment Management Ltd cut its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 15.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,498 shares of the biotechnology company's stock after seMay 25 at 4:56 AM | marketbeat.comVoloridge Investment Management LLC Invests $23.20 Million in Biogen Inc. (NASDAQ:BIIB)Voloridge Investment Management LLC acquired a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 151,678 shares of the biotechnology companyMay 25 at 4:55 AM | marketbeat.comWoodline Partners LP Grows Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Woodline Partners LP increased its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 7.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 88,157 shares of the biotechnology company's stock after purchasing an addiMay 24 at 5:02 AM | marketbeat.comTidal Investments LLC Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Tidal Investments LLC increased its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 110.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,959 shares of the biotechnology company's sMay 24 at 4:45 AM | marketbeat.comState of Wyoming Purchases Shares of 2,505 Biogen Inc. (NASDAQ:BIIB)State of Wyoming purchased a new stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,505 shares of the biotechnology company's stock, valued at approximately $38May 23 at 5:16 AM | marketbeat.comToronto Dominion Bank Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Toronto Dominion Bank boosted its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 20.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,671 shares of the biotechnology company's stocMay 23 at 5:15 AM | marketbeat.comJanus Henderson Group PLC Has $3.02 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Janus Henderson Group PLC trimmed its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 14.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,763 shares of the biotechnology company's stock after selling 3,2May 23 at 3:45 AM | marketbeat.comBiogen Q1 Earnings TranscriptMay 22 at 7:01 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Holdings Lifted by Worldquant Millennium Advisors LLCWorldquant Millennium Advisors LLC grew its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 214.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 461,120 shares of the biotechnology company's stock after purcMay 22 at 6:52 AM | marketbeat.comNuveen Asset Management LLC Has $45.99 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Nuveen Asset Management LLC cut its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 300,741 shares of the biotechnology company's stock aMay 22 at 4:24 AM | marketbeat.comTriglav Skladi D.O.O. Makes New $2.76 Million Investment in Biogen Inc. (NASDAQ:BIIB)Triglav Skladi D.O.O. purchased a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 18,027 shares of the biotechnology company's stock, valued at approximately $2,756,000. Several other hedge fundMay 21, 2025 | marketbeat.comTwo Sigma Advisers LP Boosts Stake in Biogen Inc. (NASDAQ:BIIB)Two Sigma Advisers LP raised its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 25.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 534,600 shares of the biotechnology company's stock after acquiring an additional 107,000 sharMay 21, 2025 | marketbeat.comTwo Sigma Investments LP Raises Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Two Sigma Investments LP increased its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 31.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 852,336 shares of the biotechnology company's stock aMay 21, 2025 | marketbeat.comTema Etfs LLC Invests $382,000 in Biogen Inc. (NASDAQ:BIIB)Tema Etfs LLC bought a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,501 shares of the biotechnology company's stock, valued at approximately $382,00May 21, 2025 | marketbeat.comDo Wall Street Analysts Like Biogen Stock?May 21, 2025 | msn.comCresset Asset Management LLC Reduces Position in Biogen Inc. (NASDAQ:BIIB)Cresset Asset Management LLC cut its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 80.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,341 shares of the biotechnology company's stock after sMay 21, 2025 | marketbeat.comZacks Research Has Pessimistic Outlook of Biogen Q2 EarningsBiogen Inc. (NASDAQ:BIIB - Free Report) - Zacks Research cut their Q2 2025 earnings estimates for shares of Biogen in a research note issued on Thursday, May 15th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will post earnings of $4.09 per share for the quarter, dMay 20, 2025 | marketbeat.comSuvretta Capital Management LLC Grows Position in Biogen Inc. (NASDAQ:BIIB)Suvretta Capital Management LLC lifted its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 285.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,436 shares of the biotechnology company's stoMay 19, 2025 | marketbeat.comSiemens Fonds Invest GmbH Purchases 8,801 Shares of Biogen Inc. (NASDAQ:BIIB)Siemens Fonds Invest GmbH boosted its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 159.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 14,321 shares of the biotechnology company's stock after purchasing an additional 8,801 sharMay 19, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Acquired by ProShare Advisors LLCProShare Advisors LLC lifted its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 17.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 198,326 shares of the biotechnology company's stock afMay 19, 2025 | marketbeat.comMufg Securities Americas Inc. Takes $329,000 Position in Biogen Inc. (NASDAQ:BIIB)Mufg Securities Americas Inc. purchased a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,151 shares of the biotechnology company's stock, valuedMay 19, 2025 | marketbeat.com4,411 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Sig Brokerage LPSig Brokerage LP acquired a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 4,411 shares of the biotechnology company's stock, valued at approximatelyMay 18, 2025 | marketbeat.comRafferty Asset Management LLC Purchases 29,319 Shares of Biogen Inc. (NASDAQ:BIIB)Rafferty Asset Management LLC lifted its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 18.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 189,520 shares of the biotechnology company's stock after acquiring an additiMay 18, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Trims Stake in Biogen Inc. (NASDAQ:BIIB)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 10.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 117,240 shares of the biotechnology company's stock after sellingMay 18, 2025 | marketbeat.comPoint72 Hong Kong Ltd Makes New $4 Million Investment in Biogen Inc. (NASDAQ:BIIB)Point72 Hong Kong Ltd bought a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 26,179 shares of the biotechnology company's stock, valued at approximately $4,003,000. A number of other instMay 17, 2025 | marketbeat.comLazard Asset Management LLC Purchases 30,619 Shares of Biogen Inc. (NASDAQ:BIIB)Lazard Asset Management LLC raised its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 128.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 54,476 shares of the biotechnology company's stoMay 17, 2025 | marketbeat.comEnsign Peak Advisors Inc Has $3.31 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Ensign Peak Advisors Inc lowered its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 10.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,669 shares of the biotechnology company's stock after sellingMay 17, 2025 | marketbeat.comAmeriprise Financial Inc. Has $22.02 Million Stake in Biogen Inc. (NASDAQ:BIIB)Ameriprise Financial Inc. trimmed its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 87.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 144,023 shares of the biotechnology company's stock aftMay 17, 2025 | marketbeat.comPatient Capital Management LLC Has $63.30 Million Stake in Biogen Inc. (NASDAQ:BIIB)Patient Capital Management LLC lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 61.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 413,960 shares of the biotechnology companyMay 16, 2025 | marketbeat.comMan Group plc Sells 170,285 Shares of Biogen Inc. (NASDAQ:BIIB)Man Group plc decreased its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 19.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 686,550 shares of the biotechnology company's stock after selling 170,285 shares during the quarterMay 16, 2025 | marketbeat.comLMR Partners LLP Acquires 6,379 Shares of Biogen Inc. (NASDAQ:BIIB)LMR Partners LLP increased its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 78.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,500 shares of the biotechnology company's stock after purchasing an addiMay 16, 2025 | marketbeat.comCaptrust Financial Advisors Purchases 3,218 Shares of Biogen Inc. (NASDAQ:BIIB)Captrust Financial Advisors lifted its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 49.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,712 shares of the biotechnology companMay 16, 2025 | marketbeat.comBaird Financial Group Inc. Sells 20,782 Shares of Biogen Inc. (NASDAQ:BIIB)Baird Financial Group Inc. trimmed its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 70.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,660 shares of the biotechnology company's stock after seMay 16, 2025 | marketbeat.comBIIB Q1 Earnings Call: New Product Growth Outpaces Declining MS Franchise Amid Lowered GuidanceMay 15, 2025 | msn.comBiogen Inc. (BIIB): Among Small-Cap Healthcare Stocks Hedge Funds Are BuyingMay 15, 2025 | msn.comOrbimed Advisors LLC Sells 303,900 Shares of Biogen Inc. (NASDAQ:BIIB)Orbimed Advisors LLC reduced its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 37.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 509,100 shares of the biotechnology compMay 15, 2025 | marketbeat.com2,347 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by MJP Associates Inc. ADVMJP Associates Inc. ADV acquired a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 2,347 shares of the biotechnology company's stock, valued at approximatelMay 15, 2025 | marketbeat.comCentiva Capital LP Lowers Stake in Biogen Inc. (NASDAQ:BIIB)Centiva Capital LP trimmed its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 70.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,858 shares of the biotechnology company's stock after selling 4,487 shares during the quarter. CentivMay 15, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Letko Brosseau & Associates Inc.Letko Brosseau & Associates Inc. lessened its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,582 shares of the biotechnology companyMay 14, 2025 | marketbeat.comGraham Capital Management L.P. Invests $2.04 Million in Biogen Inc. (NASDAQ:BIIB)Graham Capital Management L.P. purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 13,357 shares of theMay 14, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Stock Holdings Raised by Ethic Inc.Ethic Inc. lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 108.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,912 shares of the biotechnology company's stock after purchasing an additional 7,743 shares during the periMay 14, 2025 | marketbeat.comWhy Biogen Inc. (BIIB) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing BoomMay 13, 2025 | msn.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Hudson Bay Capital Management LPHudson Bay Capital Management LP reduced its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 19.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 241,008 shares of the biotechnology company's stMay 13, 2025 | marketbeat.comGotham Asset Management LLC Buys 47,182 Shares of Biogen Inc. (NASDAQ:BIIB)Gotham Asset Management LLC raised its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 111.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 89,626 shares of the biotechnology company's stock after purchasing an additional 47,18May 13, 2025 | marketbeat.comBiogen Completes $1.75 Billion Notes IssuanceMay 12, 2025 | tipranks.comRep. Robert Bresnahan, Jr. Sells Biogen Inc. (NASDAQ:BIIB) StockRepresentative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Biogen Inc. (NASDAQ:BIIB). In a filing disclosed on May 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Biogen stock on April 8th. The trade occurred in the Representative's "JP MORGANMay 12, 2025 | marketbeat.comDeutsche Bank AG Buys 455,285 Shares of Biogen Inc. (NASDAQ:BIIB)Deutsche Bank AG grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 63.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,169,570 shares of the biotechnology company's stock after acquiring an additional 455,285 shareMay 12, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am MainDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main decreased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,818 shares of tMay 12, 2025 | marketbeat.comJeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior PrincipalMay 12, 2025 | globenewswire.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼1.370.75▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼2723▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today United Therapeutics News Today Exelixis News Today Incyte News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.